About us Contacts Interactions: 12170
Drug search by name

Baricitinib and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)

Result of checking the interaction of Baricitinib and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia) for safety when used together.

Check result:
Baricitinib <> High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Relevance: 03.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug interaction with food or lifestyle.

Consumer:

In controlled clinical trials, baricitinib treatment was associated with dose-related increases in lipid parameters including total cholesterol, triglycerides, LDL cholesterol, and HDL cholesterol. It is recommended to evaluate lipid parameters at baseline and approximately 12 weeks following initiation of treatment. Manage patients according to clinical guidelines for the management of hyperlipidemia.

Professional:

In controlled clinical trials, baricitinib treatment was associated with dose-related increases in lipid parameters including total cholesterol, triglycerides, LDL cholesterol, and HDL cholesterol. It is recommended to evaluate lipid parameters at baseline and approximately 12 weeks following initiation of treatment. Manage patients according to clinical guidelines for the management of hyperlipidemia.

Baricitinib

Generic Name: baricitinib

Brand Name: Olumiant

Synonyms: n.a.

Disease interaction
Drug interactions